Sutton Wealth Advisors Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Sutton Wealth Advisors Inc.

  • $203 Billion
  • Q3 2023

A detailed history of Sutton Wealth Advisors Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sutton Wealth Advisors Inc. holds 47 shares of REGN stock, worth $47,602. This represents 0.02% of its overall portfolio holdings.

Number of Shares
47
Previous 34 38.24%
Holding current value
$47,602
Previous $24.4 Million 58.33%
% of portfolio
0.02%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$692.45 - $844.37 $9,001 - $10,976
13 Added 38.24%
47 $38.7 Million
Q1 2023

Nov 07, 2023
SELL
$680.49 - $826.97 $1,360 - $1,653
-2 Reduced 5.56%
34 $27.9 Million
Q4 2022

Nov 07, 2023
SELL
$705.89 - $766.39 $2,117 - $2,299
-3 Reduced 7.69%
36 $26 Million
Q3 2022

Nov 07, 2023
BUY
$573.97 - $724.32 $1,721 - $2,172
3 Added 8.33%
39 $26.9 Million
Q1 2022

Nov 07, 2023
BUY
$595.12 - $698.43 $1,785 - $2,095
3 Added 9.09%
36 $25.1 Million
Q3 2021

Nov 07, 2023
SELL
$574.03 - $680.96 $1,148 - $1,361
-2 Reduced 5.71%
33 $20 Million
Q1 2021

Nov 07, 2023
SELL
$446.73 - $548.2 $446 - $548
-1 Reduced 2.78%
35 $16.6 Million
Q4 2020

Nov 07, 2023
BUY
$478.3 - $607.98 $1,913 - $2,431
4 Added 12.5%
36 $17.4 Million
Q1 2020

Nov 07, 2023
BUY
$336.18 - $494.43 $2,689 - $3,955
8 Added 33.33%
32 $15.6 Million
Q3 2019

Nov 07, 2023
BUY
$273.46 - $318.39 $273 - $318
1 Added 4.35%
24 $6.66 Million
Q2 2019

Nov 06, 2023
SELL
$299.6 - $414.82 $898 - $1,244
-3 Reduced 11.54%
23 $7.2 Million
Q4 2018

Nov 06, 2023
BUY
$335.82 - $403.04 $1,007 - $1,209
3 Added 13.04%
26 $9.71 Million
Q1 2018

Nov 06, 2023
SELL
$315.82 - $393.78 $11,369 - $14,176
-36 Reduced 61.02%
23 $7.92 Million
Q4 2017

Nov 06, 2023
SELL
$358.63 - $469.95 $717 - $939
-2 Reduced 3.28%
59 $22.2 Million
Q3 2017

Nov 06, 2023
BUY
$431.38 - $504.0 $862 - $1,008
2 Added 3.39%
61 $27.3 Million
Q1 2017

Nov 06, 2023
SELL
N/A
-3 Reduced 4.84%
59 $22.9 Million
Q4 2016

Nov 06, 2023
BUY
N/A
3 Added 5.08%
62 $22.8 Million
Q3 2016

Nov 06, 2023
BUY
N/A
2 Added 3.51%
59 $23.7 Million
Q2 2016

Nov 06, 2023
BUY
N/A
36 Added 171.43%
57 $19.9 Million
Q1 2016

Nov 06, 2023
BUY
N/A
21
21 $7.57 Million

Others Institutions Holding REGN

# of Institutions
1,464
Shares Held
84.4M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $109B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email